Kell Blood Group System and the McLeod Syndrome

  • Colvin M. Redman
  • Soohee Lee
Part of the Blood Cell Biochemistry book series (BLBI, volume 6)


The Kell blood group system was named after the person who made the first recognized antibody. Other than ABO, the Kell antigens are perhaps only second to the D antigen in the Rh system as potent immunogens. About 5% of K:−1 persons who are transfused with a single unit of K:1 red cells make anti-K1 IgG. The Kell blood group system is important not only in transfusion but also clinically since K1 is present on red cells of fetuses and maternal alloimmunization may cause hemolytic disease in the newborn.


Duchenne Muscular Dystrophy Chronic Granulomatous Disease Blood Group System Common Acute Lymphoblastic Leukemia Antigen McLeod Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allen, F. H., Krabbe, S. M. R., and Concoran. P. A., 1961, A new phenotype (McLeod) in the Kell blood-group system. Vox Sang. 6: 555–560.PubMedCrossRefGoogle Scholar
  2. Anstee, D. J., 1990, Blood group-active surface molecules of the human red blood cells, Vox Sang. 58: 1–20.PubMedCrossRefGoogle Scholar
  3. Ballas, S. K., Bator. S. M.. Aubuchon. J. P., Marsh, W. L., Sharp, D. E., and Toy, E. M., 1990. Abnormal membrane physical properties of red cells in McLeod syndrome, Transfusion. 30: 722–727.PubMedCrossRefGoogle Scholar
  4. Bertelson, C. J., Pogo, A. O., Chadhuri, A., Redman, C. M., Banerjee, D.. Symmans, W. A., Simon, T., and Kunkel, L. M., 1988, Localization of the McLeod locus (XK) within Xp21 by deletion analysis, Am. J. Hum. Genet. 423: 703–711.Google Scholar
  5. Branch, D. R.. and Petz, L. D., 1982, A new reagent (ZZAP) having multiple applications in immunohematology, Am. J. Clin. Pathol. 78: 161–167.PubMedGoogle Scholar
  6. Branch, D. R., Muensch, H. A., Siok Hian, H. L. S.. and Petz, L. D., 1983, Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity, Br. J. Haematol. 54: 573–578.PubMedCrossRefGoogle Scholar
  7. Chou, P. Y., and Fasman. G. D., 1978, Empirical predictions of protein conformation. Annu. Rev. Biochem. 47: 251–276.PubMedCrossRefGoogle Scholar
  8. Clarke, S., 1992, Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61: 355–386.PubMedCrossRefGoogle Scholar
  9. Connelly, J. C., Skidgel, A., Schultz, W. W.. Johnson. A. R., and Erdos. E. G., 1985, Neutral endopeptidase 24.11 in human neutrophils: Cleavage of chemotactic peptide, Proc. Natl. Acad. Sci. USA 82: 8737–8741.PubMedCrossRefGoogle Scholar
  10. Engelman, D. M., Steitz. T. A.. and Goldman, A., 1986. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins, Annu. Rev. Biophys. Biophys. Chem. 15: 321–353.PubMedCrossRefGoogle Scholar
  11. Francke, U., Ochs, H. D.. de Martinville, B., Giacalone, J., Lindgren, V., Disteche, C. M., Pagan, R. A., Hofker, M. H., van Ommen. G. J. B., Pearson, P. L., and Wedgewood, R. J., 1985, Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa and the McLeod syndrome. Am. J. Hum. Genet. 37: 250–267.PubMedGoogle Scholar
  12. Gafford, J. T., Skidgel, R. A., Erdos, E. G., and Hersh, L. B., 1983, Human kidney “enkephalinase” a neutral metalloendopeptidase that cleaves active peptides, Biochemistry 22: 3265–3271.PubMedCrossRefGoogle Scholar
  13. Galey, W. R., Evan, A. P., VanNice. P. S., Dail, W. G.. Wirner, B. M., and Cooper, R. A. 1978. Morphology and physiology of the McLeod Erythrocyte: I. Scanning electron microscopy and electrolyte and water transport properties. Vox Sang. 34: 152–161.PubMedCrossRefGoogle Scholar
  14. Getman, D. K., Eubanks, J. H., Camp. S., Evans, G. A., and Taylor, P. 1992, The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am. J. Hum. Genet. 51: 170–177.PubMedGoogle Scholar
  15. Glaubensklee, C. S., Evan, A. P., and Galey, W. R., 1982, Structural and biochemical analysis of the McLeod erythrocyte membrane. I. Freeze fracture and discontinuous polyacrylamide gel electrophoresis analysis. Vox Sang. 42: 262–271.PubMedCrossRefGoogle Scholar
  16. Ho, M. F., Monaco, A. P.. Blouden, L. A. J., Van Ommen, G. J. B.. Affara, N. A.. Ferguson-Smith, M. A., and Lehrach, H.. I992a, Fine mapping of the McLeod locus (XK) to a 150–350 kb region in Xp21, Am. J. Hum. Genet. 50: 317–330.Google Scholar
  17. Ho, M. F., Clarke. J., Chelly, J., and Monaco. A. P., 19926, Isolation of cDNA clones from the McLeod syndrome critical region, Annual meeting of the American Society of Human Genetics (Abstract) A21.Google Scholar
  18. Ho, M.. Chelly, J., Carter, N., Dane. K. A., Crocker, P., and Monaco, A. P., 1994, Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein, Cell 77: 869–880.PubMedCrossRefGoogle Scholar
  19. Jaber, A., Blanchard, D., Goossens, D., Bloy, C., Lambin, P.. Rouger, P., Salmon, C., and Cartron, J.-P., 1989, Characterization of blood group Kell (KI) antigen with a human monoclonal antibody, Blood. 73: 1597–1602.PubMedGoogle Scholar
  20. Hughes-Jones, N. C., and Gardner, B.. 1971, The Kell system: studies with radiolabeled anti-K. Vox Sanguinis 21: 154–158.PubMedCrossRefGoogle Scholar
  21. Jaber, A., Loirat, M. J., Willem, C., Bloy, C., Cartron, J.-P., and Blanchard. D., 1991, Characterization of murine monoclonal antibodies directed against the Kell blood group glycoprotein, Br. J. Haematol. 79: 311–315.PubMedCrossRefGoogle Scholar
  22. Kenny, A. J., O’Hare, M. J.. and Gusterson, B. A., 1989, Cell surface peptidases as modulators of growth and differentiation, Lancet 2: 785–787.PubMedCrossRefGoogle Scholar
  23. Khodadad, J. K., Weinstein, R. S. Marsh, W. L., and Steck, T. L.. 1989. Shape determinants of McLeod acanthocytes, J. Membr. Biol. 107: 213–218.PubMedCrossRefGoogle Scholar
  24. Kuypers, F. A., Van Linde Sibenius Trip, M., Roelofsen, B., Opdenkamp, J. A. F.,Tanner, M. J. A., and Anstee, D. J., 1985, The phospholipid organizations in the membranes of McLeod and Leach phenotype erythrocytes, Fed. Eur. Biochem. Soc. 184:20–24.Google Scholar
  25. Lee, S., and Redman. C., 1988, Kell blood group proteins, J. Cell Biol. 197: 560a (abstract).Google Scholar
  26. Lee, S., Zambas, E., Marsh, W. L., and Redman, C. M., 1991, Molecular cloning and primary structure of Kell blood group protein, Proc. Nat!. Acad. Sci. USA 88: 6353–6357.PubMedCrossRefGoogle Scholar
  27. Lee, S., Zambas, E. D., and Redman. C. M., 1992, Characterization of the gene encoding the human Kell blood group antigens, Mol. Biol. Cell 3: 81a (abstract).Google Scholar
  28. Lee, S., Zambas, E. D., Marsh, W. L., and Redman, C. M., 1993, The human Kell blood group gene maps to 7833 and its expression is restricted to erythroid cells. Blood 10: 2804–2809.Google Scholar
  29. Letarte, M., Vera, S.. Tran, R., Addis, J. B. L., Onizuka, R. J., Quackenbush, E. J.. Jongeneel, C. V., and McInnes, R. R., 1988. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase, J. Exp. Med. 168: 1247–1253.PubMedCrossRefGoogle Scholar
  30. Lozzio, C. B., and Lozzio, B. B.. 1975, Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome, Blood 45: 321–334.PubMedGoogle Scholar
  31. McGinness, M. H., and Dean, A., 1985, Expression of red cell antigens by K562 human leukemia cells before and after induction of hemoglobin synthesis by hemin, Transfusion 25: 105–109.CrossRefGoogle Scholar
  32. Malfroy, B., Kuang, W.-J., Seeburg. P. H., Mason, A. J., and Schofield, P. R., 1988, Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase), FEBS Lett. 229: 206–210.PubMedCrossRefGoogle Scholar
  33. Marsh, W. L., and Redman, C. M., 1987, Recent developments in the Kell blood group system, Trans-fus. Med. Rev. 1: 4–20.CrossRefGoogle Scholar
  34. Marsh, W. L., and Redman, C. M., 1990, The Kell blood group system: A review, Transfusion 30: 158–167.PubMedCrossRefGoogle Scholar
  35. Marsh, W. L., Oyen, R., Nichols, M. E., and Allen, F. H., 1975, Chronic granulomatous disease and the Kell blood groups, Br. J. Haematol. 29: 247–262.PubMedCrossRefGoogle Scholar
  36. Marsh, W. L., Marsh, N. J., Moore, A., Symmans, W. A., Johnson, C. L., and Redman, C. M., 1981, Elevated serum creative phosphokinase in subjects with McLeod syndrome, Vox Sang. 40: 403–411.PubMedCrossRefGoogle Scholar
  37. Masouredis, S. P., Sudora, E.. Mohan, L. C., and Victoria, E. J., 1980, Immunoelectron microscopy of Kell and Cellano antigens on red cell ghosts, Haematologia 13: 59–64.PubMedGoogle Scholar
  38. Parsons, S. F., Gardner, B., and Anstee, D. J., 1993, Monoclonal antibodies against Kell glycoprotein: serology, immunochemistry and quantitation of antigen sites, Transfus. Med. 3: 137–142.PubMedCrossRefGoogle Scholar
  39. Rao, H., Whitsett, C. F., Oxendine, S. M., and Telen, M. J., 1993, Human erythrocyte acetylcholinesterase bears the Yt blood group antigen and is reduced or absent in the Yt (a— b—) phenotype. Blood 81: 8–15.Google Scholar
  40. Redman, C. M., Marsh, W. L., Mueller, K. A., Avellino, G. P., and Johnson, C. L., 1984, Isolation of Kell-active protein from the red cell membrane, Transfusion 24: 176–178.PubMedCrossRefGoogle Scholar
  41. Redman, C. M., Avellino, G., Pfeffer, S. R., Mukherjee, T. K., Nichols, M., Rubinstein, P., and Marsh, W. L., 1986, Kell blood group antigens are part of a 93,000 dalton red cell membrane protein, J. Biol. Chem. 261: 9521–9525.PubMedGoogle Scholar
  42. Redman, C. M., Marsh, W. L., Scarborough, A., Johnson, C. L., Rabin, B. I., and Overbeeke, M., 1988, Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen. Br. J. Haematol. 68: 131–136.PubMedCrossRefGoogle Scholar
  43. Redman, C. M., Huima, T., Robbins, E., Lee, S., and Marsh, W. L., 1989a, Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood 74: 1826–1835.PubMedGoogle Scholar
  44. Redman, C. M., Lee, S., Ten Bokkel Huinink, D., Rabin, B. 1., Johnson, C. L., Oyen, R., and Marsh, W. L., 1989b, Comparison of human and chimpanzee Kell blood group systems, Transfusion 29: 486–490.PubMedCrossRefGoogle Scholar
  45. Russo, D., Lee, S., and Redman, C. M., 1993, Transfected cells express a Kell blood group protein with multiple antigens, Am. Soc. Cell Biol. (abstract).Google Scholar
  46. Shipp, M. A., Richardson, N. E., Sayre, P. H., Brown, N. R., Masteller, E. L., Clayton, L. K., Ritz, J., and Reinherz, E. L., 1988, Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein, Proc. Nail. Acad. Sci. USA 85: 4819–4823.CrossRefGoogle Scholar
  47. Shipp, M. A., Vijayaraghavan. J., Schmidt, E. V., Masteller, E. L., D’Adamio, L. B., Hersh, L. D., and Reinherz, E. L.. 1989, Common acute lymphoblastic antigen (CALLA) is active neutral endopeptidase 24.11 (`enkephalinase“): Direct evidence by cDNA transfected analysis, Proc. Natl. Acad. Sci. USA 86: 297–301.Google Scholar
  48. Spence, M. A., Falk, C. T., Neiswanger, K., Field, L. L.. Marazita, M. L., Allen, F. H., Siergovel, R. M., Roche, A. F., Cradall, B. F., and Sparkes. R. S., 1984, Estimating the recombination frequency for the PTC-Kell linkage. Hum. Genet. 678: 183–186.CrossRefGoogle Scholar
  49. Spring, F. A., and Anstee, D. J. 1991. Evidence that Yt blood group antigens are located on human acetyldrolinesterase (AchE), Transfus. Med. Res. 1: 42 (Abstract suppl. 2).Google Scholar
  50. Symmans, W. A., Shepherd, C. S., Marsh, W. L., Oyen, R., Shohet. S. B., and Linehan, B. J., 1979, Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system, Br. J. Haematol. 42: 575–583.PubMedCrossRefGoogle Scholar
  51. Tang, L. L., Redman, C. M., Williams, D., and Marsh. W. L., 1981, Biochemical studies on McLeod phenotype erythrocytes. Vox Sang. 40: 17–26.PubMedCrossRefGoogle Scholar
  52. Wainfan, E.. Kilkenny, M.. Johnson, C., and Marsh, W. L.. 1991. Reduced membrane protein methylation in red cells of the McLeod blood group phenotype, Transfusion 31: 805–809.PubMedCrossRefGoogle Scholar
  53. Wimmer, B. M., Marsh. W. L., Taswell, H. F., and Galey, H. R.. 1977, Haematological changes associated with the McLeod phenotype of the Kell blood group system, Br. J. Haematol. 36: 219–224.CrossRefGoogle Scholar
  54. Wu, Q., Lahti, J. M., Air, G. M., Burrows, P. D.. and Cooper, M. D., 1990. Molecular cloning of the murine Bp-1/6C3 antigen: A member of the zinc-dependent metallopeptidase family. Proc. Natl. Acad. Sci. USA 87: 993–997.PubMedCrossRefGoogle Scholar
  55. Zelinski, T., Coghlan, G., Myal, L., Shin, R. P. C., Philips, S., White, L., and Lewis. M. 1991, Genetic linkage between the Kell blood group system and prolactin-inducible protein loci: provisional assignment of KEL to chromosome 7, Ann. Hum. Genet. 55: 137–140.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Colvin M. Redman
    • 1
  • Soohee Lee
    • 1
  1. 1.Department of Biochemistry, Lindsley F. Kimball Research InstituteThe New York Blood CenterNew YorkUSA

Personalised recommendations